| 0.9564 0.135 (16.49%) | 05-06 14:07 | |||||||||||||
|
|
| Short term | |
|||
| Mid term | ||||
| Targets | 6-month : | 1.21 | 1-year : | 1.43 |
| Resists | First : | 1.03 | Second : | 1.23 |
| Pivot price | 0.87 |
|||
| Supports | First : | 0.72 | Second : | 0.6 |
| MAs | MA(5) : | 0.82 |
MA(20) : | 0.89 |
| MA(100) : | 1.4 |
MA(250) : | 3.73 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 35.2 |
D(3) : | 22.3 |
| RSI | RSI(14): 48.4 |
|||
| 52-week | High : | 10.94 | Low : | 0.72 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ AIFC ] has closed below upper band by 20.4%. Bollinger Bands are 60.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 13 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 0.87 - 0.88 | 0.88 - 0.88 |
| Low: | 0.79 - 0.8 | 0.8 - 0.8 |
| Close: | 0.81 - 0.82 | 0.82 - 0.83 |
AI Financial Corporation, together with its subsidiaries, provides blockchain-powered technologies worldwide. It operates through Fintech and Biotechnology segments. The company engages in the tokenization, trading, clearing settlement, payment, and safe keeping of digital assets. Its products include ALT 5 Prime, an electronic over-the-counter trading platform for the buying and selling of digital assets; and ALT 5 Pay, a crypto-currency payment gateway that enables merchants to accept and make crypto currency payments or integrate the payment platform into their application. The company is also involved identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies for the treatment of pain and addiction. In addition, it develops JAN 101, an oral and sustained-release pharmaceutical composition of sodium nitrite that has completed Phase 2a clinical trial to treat peripheral arterial disease and pain; and JAN123, a formulation of low-dose naltrexone for the treatment of chronic regional pain syndrome. The company was formerly known as ALT5 Sigma Corporation and changed its name to AI Financial Corporation in April 2026. AI Financial Corporation was founded in 1976 and is based in Las Vegas, Nevada.
Mon, 04 May 2026
AIFC Stock Price, Quote & Chart | AI FINANCIAL CORP (NASDAQ:AIFC) - ChartMill
Sat, 02 May 2026
AIFC Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Fri, 01 May 2026
AI Financial Corporation (NASDAQ: AIFC) rebrands from ALT5 Sigma with new ticker - Stock Titan
Fri, 01 May 2026
Canaan Partners IX LLC's AI Financial Corp(AIFC) Holding History - GuruFocus
Fri, 01 May 2026
Pretax income of AI Financial Corporation – NASDAQ:AIFC - TradingView
Thu, 30 Apr 2026
AI FINANCIAL CP (AIFC) Cash From Investing (TTM) - Zacks Investment Research
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Industrials
|
|
|
Industry:
Environmental Services
|
|
| Shares Out | 140 (M) |
| Shares Float | 104 (M) |
| Held by Insiders | 2 (%) |
| Held by Institutions | 37.2 (%) |
| Shares Short | 15,100 (K) |
| Shares Short P.Month | 15,720 (K) |
| EPS | -5.87 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 9.02 |
| Profit Margin | 0 % |
| Operating Margin | -48.2 % |
| Return on Assets (ttm) | -2.3 % |
| Return on Equity (ttm) | -58 % |
| Qtrly Rev. Growth | 12.5 % |
| Gross Profit (p.s.) | 0.07 |
| Sales Per Share | 0.17 |
| EBITDA (p.s.) | -0.14 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -7 (M) |
| Levered Free Cash Flow | 2 (M) |
| PE Ratio | -0.17 |
| PEG Ratio | 0.9 |
| Price to Book value | 0.1 |
| Price to Sales | 5.34 |
| Price to Cash Flow | -18.54 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |